Role of the ROS/AMPK signaling pathway in tetramethylpyrazine-induced apoptosis in gastric cancer cells

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 583-589

  Yi, Bo ^a,b   Liu, Dan ^a   He, Ming ^a   Li, Qiyun ^b   Liu, Tiande ^a   Shao, Jianghua ^a  

^a NANCHANG UNIVERSITY   (China)

^b Jiangxi Province Tumor Hospital   (China)

Author keywords

AMP activated protein kinase; Apoptosis; Gastric cancer cell; Mitochondria; Reactive oxygen species; Tetramethylpyrazine

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIGUSTICUM CHUANXIONG EXTRACT; REACTIVE OXYGEN METABOLITE; TETRAMETHYLPYRAZINE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRIAL MEMBRANE POTENTIAL; SIGNAL TRANSDUCTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 84879469652     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1403     Document Type: Article

References (29)

1. Liu X, Liu H, Zeng Z, Zhou W, Liu J and He Z: Pharmacokinetics of ligustrazine ethosome patch in rats and anti-myocardial ischemia and anti-ischemic reperfusion injury effect. Int J Nanomedicine 6: 1391-1398, 2011.
2. Liang X, Zhou H, Ding Y, Li J, Yang C, Luo Y, Li S, Sun G, Liao X and Min W: TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model. Invest Ophthalmol Vis Sci 53: 2157-2169, 2012.
3. Yu K, Chen Z, Pan X, Yang Y, Tian S, Zhang J, Ge J, Ambati B and Zhuang J: Tetramethylpyrazine-mediated suppression of C6 gliomas involves inhibition of chemokine receptor CXCR4 expression. Oncol Rep 28: 955-960, 2012.
4. Zheng CY, Xiao W, Zhu MX, Pan XJ, Yang ZH and Zhou SY: Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis. Int J Oncol 40: 2029-2037, 2012.
5. Carling D, Thornton C, Woods A and Sanders MJ: AMP-activated protein kinase: new regulation, new roles? Biochem J 445: 11-27, 2012.
6. Webster I, Friedrich SO, Lochner A and Huisamen B: AMP kinase activation and glut4 translocation in isolated cardiomyocytes. Cardiovasc J Afr 21: 72-78, 2010.
7. Park JB, Lee MS, Cha EY, Lee JS, Sul JY, Song IS and KimJY: Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway. Biol Pharm Bull 35: 1614-1620, 2012.
8. Liu L, Ulbrich J, Müller J, Wüstefeld T, Aeberhard L, Kress TR, Muthalagu N, Rycak L, Rudalska R, Moll R, etal: Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 483: 608-612, 2012.
9. Chen G, Zhang X, Zhao M, Wang Y, Cheng X, Wang D, XuY, Du Z and Yu X: Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells. BMC Cancer 11: 170, 2011.
10. Miki H, Uehara N, Kimura A, Sasaki T, Yuri T, Yoshizawa K and Tsubura A: Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol 40: 1020-1028, 2012.
11. Zheng F, Yang WJ, Sun KJ, Wan XM, Man N and Wen LP: Hoechst 33342-induced autophagy protected HeLa cells from caspase-independent cell death with the participation of ROS. Free Radic Res 46: 740-749, 2012.
12. Jang KY, Jeong SJ, Kim SH, Jung JH, Kim JH, Koh W, ChenCY and Kim SH: Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells. Cancer Lett 319: 197-202, 2012.
13. +-ATPase activity in skeletal muscle cells. J Biol Chem 287: 23451-23463, 2012.
14. Landes T and Martinou JC: Mitochondrial outer membrane permeabilization during apoptosis: the role of mitochondrial fission. Biochim Biophys Acta 1813: 540-545, 2011.
15. Sampieri K and Fodde R: Cancer stem cells and metastasis. Semin Cancer Biol 22: 187-193, 2012.
16. Zhao J, Lu Y and Shen HM: Targeting p53 as a therapeutic strategy in sensitizing TRAIL-induced apoptosis in cancer cells. Cancer Lett 314: 8-23, 2012.
17. Wang P, She G, Yang Y, Li Q, Zhang H, Liu J, Cao Y, Xu X and Lei H: Synthesis and biological evaluation of new ligustrazine derivatives as anti-tumor agents. Molecules 17: 4972-4985, 2012.
18. Zhang Y, Liu X, Zuo T, Liu Y and Zhang JH: Tetramethylpyrazine reverses multidrug resistance in breast cancer cells through regulating the expression and function of P-glycoprotein. Med Oncol29: 534-538, 2012.
19. Hardie DG: AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 25: 1895-1908, 2011.
20. Alexander A and Walker CL: The role of LKB1 and AMPK in cellular responses to stress and damage. FEBS Lett 585: 952-957, 2011.
21. El-Masry OS, Brown BL and Dobson PR: Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds. Oncol Lett 3: 224-228, 2012.
22. Kourelis TV and Siegel RD: Metformin and cancer: new applications for an old drug. Med Oncol 29: 1314-1327, 2012.
23. Petti C, Vegetti C, Molla A, Bersani I, Cleris L, Mustard KJ, Formelli F, Hardie GD, Sensi M and Anichini A: AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway. Melanoma Res 22: 341-350, 2012.
24. Scatena R: Mitochondria and cancer: a growing role in apoptosis, cancer cell metabolism and dedifferentiation. Adv Exp Med Biol942: 287-308, 2012.
25. Jourdain A and Martinou JC: Mitochondrial outer-membrane permeabilization and remodelling in apoptosis. Int J Biochem Cell Biol 41: 1884-1889, 2009.
26. Leibowitz B and Yu J: Mitochondrial signaling in cell death via the Bcl-2 family. Cancer Biol Ther 9: 417-422, 2010.
27. Walensky LD and Gavathiotis E: BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore. Trends Biochem Sci 36: 642-652, 2011.
28. Lalier L, Cartron PF, Juin P, Nedelkina S, Manon S, Bechinger B and Vallette FM: Bax activation and mitochondrial insertion during apoptosis. Apoptosis 12: 887-896, 2007.
29. Zeng L, Li T, Xu DC, Liu J, Mao G, Cui MZ, Fu X and Xu X: Death receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with Bax protein. J Biol Chem 287: 29125-29133, 2012.